|
Shares of RPRX Up 16.7% Since Uptrend Call on Shares
Jan 18, 2013 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend identified an Uptrend for Repros Therapeutics (NASDAQ:RPRX) on November 23rd, 2012 at $15.37. In approximately 2 months, Repros Therapeutics has returned 16.66% as of today's recent price of $17.93.
Over the past year, Repros Therapeutics has traded in a range of $3.34 to $18.18 and is now at $17.93, 437% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.9% while the 200-day MA has risen 2.5%.
Repros Therapeutics Inc. is a clinical stage biopharmaceutical company. The Company develops new drugs to treat hormonal and reproductive system disorders.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Repros Therapeutics shares.Log in and add Repros Therapeutics (RPRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
